Report Library
View More
Chronic Heart Failure KOL Interview...
August 15, 2022
Chronic Heart Failure KOL Interview...
August 15, 2022
Chronic Heart Failure KOL Interview...
August 15, 2022
Chronic Heart Failure KOL Interview...
August 15, 2022
Datamonitor Healthcare Urology: Ove...
August 11, 2022
Datamonitor Healthcare Oncology: Ne...
August 11, 2022
Datamonitor Healthcare I&I: Systemi...
August 10, 2022
Datamonitor Healthcare Oncology: Ho...
August 10, 2022
Datamonitor Healthcare Oncology Dis...
August 9, 2022
Datamonitor Healthcare Oncology Dis...
August 8, 2022
Impact Events
More| Date | Lead Company | Event | Type | Approval Change | Approval Likelihood |
|---|---|---|---|---|---|
| 8/15/22 | Novartis (NVS) | Ilaris for Non-Small Cell Lung Cancer (NSCLC) | Subscribers Only | Subscribers Only | Subscribers Only |
| 8/11/22 | NewAmsterdam | Obicetrapib for Dyslipidemia / Hypercholesterolemia | Subscribers Only | Subscribers Only | Subscribers Only |
| 8/10/22 | Bristol Myers Squibb (BMY) | Abecma for Multiple Myeloma (MM) | Subscribers Only | Subscribers Only | Subscribers Only |
| 8/9/22 | Verona Pharma (VRNA) | RPL554 (Inhaled) for Chronic Obstructive Pulmonary Disease (COPD) | Subscribers Only | Subscribers Only | Subscribers Only |
| 8/9/22 | Formosa Pharmaceuticals | APP13007 for Ocular Pain and/or Inflammation (Ophthalmology) | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
More| Expected Date Range | Lead Company | Drug | Expected Catalyst |
|---|---|---|---|
| 08/13/22 | Subscribers Only | Subscribers Only | Regulatory - PDUFA/Approval Decision (US) |
| 08/13/22 | Subscribers Only | Subscribers Only | Regulatory - PDUFA/Approval Decision (US) |
| 08/15/22 | Subscribers Only | Subscribers Only | Regulatory - Meeting with FDA |
| 08/17/22 | Subscribers Only | Subscribers Only | Partnership - Acquisition Completion |
| 08/17/22 | Subscribers Only | Subscribers Only | Partnership - Acquisition Completion |
